A Phase II Study of Bulk Versus Fractionated Stem Cell Infusions in Patients with Hematologic Cancers Undergoing Stem Cell Transplantation
[Protocol 12-016] |
Giralt, Sergio |
- Blood and Marrow Transplantation
- Hematology
- Multiple Myeloma
- Myelodysplastic Syndrome
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
- Chronic Lymphocytic Leukemia
- Chronic Myelocytic Leukemia
- Myelodysplastic Syndrome
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
|
A Phase II Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
[Protocol 12-035] |
Horwitz, Steven |
|
A Phase II Study of Brentuximab (SGN-35) Given Before and After Adriamycin, Vinblastine, and Dacarbazine Therapy in Older Adults with Untreated Hodgkin Lymphoma
[Protocol 11-201] |
Hamlin, Paul |
|
A Phase II Study of Bortezomib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 12-222] |
Riely, Gregory |
- Lung Cancer, Non-Small Cell
|
A Phase II Study of BMS-936558 in Patients with Previously Treated Advanced Squamous Cell Lung Cancer
[Protocol 12-284] |
Rizvi, Naiyer |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase II Study of Blinatumomab in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
[Protocol 12-069] |
Douer, Dan |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase II Study of BKM120 in Patients with Recurrent Glioblastoma and an Activated PI3K Pathway
[Protocol 12-002] |
Mellinghoff, Ingo |
|
A Phase II Study of BKM120 in Patients with Metastatic Non-Small Cell Lung Cancer
[Protocol 11-157] |
Paik, Paul |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase II Study of BKM120 in Metastatic Transitional Cell Carcinoma of the Urothelium
[Protocol 11-060] |
Bajorin, Dean |
|
A Phase II Study of Bevacizumab, Irinotecan, and Temozolomide for Relapsed or Refractory Neuroblastoma
[Protocol 10-015] |
Modak, Shakeel |
|
A Phase II Study of Bendamustine and Dexamethasone in Patients with Relapsed Amyloidosis
[Protocol 12-257] |
Landau, Heather |
|
A Phase II Study of Axitinib in Patients with Recurrent, Progressive/Metastatic Adenoid Cystic Cancer
[Protocol 12-004] |
Ho, Alan |
|
A Phase II Study of AUY922 in Patients with Myelofibrosis
[Protocol 12-076] |
Rampal, Raajit |
- Hematology
- Hematologic Disorders
- Hematologic Malignancies
- Leukemia
- Myeloproliferative Neoplasm
|
A Phase II Study of Afatinib (BIBW 2992) in Patients with Advanced HER2-Positive Esophagogastric Cancer Refractory to Trastuzumab
[Protocol 11-166] |
Janjigian, Yelena |
- Upper Gastrointestinal
- Esophageal Cancer
- Gastric Cancer
|
A Phase II Study of Adjuvant Bevacizumab, Metronomic Chemotherapy, Diet, and Exercise After Preoperative Chemotherapy for Breast Cancer
[Protocol 11-063] |
Dickler, Maura |
|
A Phase II Study of Abraxane with or without Tigatuzumab in Patients with Metastatic Triple-Negative Breast Cancer
[Protocol 11-082] |
Traina, Tiffany |
|
A Phase II Study of Abiraterone, Prednisone, and Degarelix in Men with Recurrent Prostate Cancer and a Rising PSA
[Protocol 12-187] |
Scher, Howard |
- Prostate Cancer
- Rising PSA After Primary Therapy
|
A Phase II Study of Abiraterone, Exemestane, or Both in Postmenopausal Women with ER-Positive Metastatic Breast Cancer
[Protocol 12-140] |
Traina, Tiffany |
|
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV
[Protocol 11-130] |
O'Reilly, Richard |
- Blood and Marrow Transplantation
- Lymphoma
|
A Phase II Study Evaluating the Addition of Trastuzumab to Standard Therapy for HER2-Positive Esophageal Cancers
[Protocol 12-094] |
Wu, Abraham |
|
